St. Jude Children's Research Hospital - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)

圣裘德儿童研究医院 - 艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)

基本信息

  • 批准号:
    10599563
  • 负责人:
  • 金额:
    $ 45.66万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-09-22 至 2029-06-30
  • 项目状态:
    未结题

项目摘要

ABSTRACT St. Jude Children's Research Hospital The Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) aims over the 7-year funding cycle to develop and conduct innovative behavioral, community-based, translational, therapeutic, microbicide, and vaccine trials in youth ages 13-24 years at-risk for HIV and living with HIV, with a focus on the inclusion of minors. The ATN seeks investigators with innovative thinking and novel approaches to address the public health issues facing adolescents. The St. Jude Memphis Site Consortium (SMSC), based in Memphis located in the Shelby County of TN has (1) a well-established clinical and clinical research facility at St. Jude Children's Research Hospital (former ATN site), (2) A long-standing Connect to Protect Memphis Coalition (C2P Memphis) of over 25 stakeholders (Community Based organizations, Non for Profit Groups, Memphis Schools, etc.) invested in the interests of youth and (3) established partnerships including with academia (University of Tennessee) and the local Shelby County and Tennessee state health departments. Shelby County is an Ending the HIV Epidemic Priority jurisdiction. The SMSC closely collaborating with the Westat led ATN Operations and Collaborations Center (OCC) will participate in the development of clinical trials and provide the clinical research site(s), local laboratory capacity, and investigational pharmacy support to further the ATN Research agenda. Taking the clinical trials to youth at risk of HIV and those living with HIV who are not aware of their diagnosis will require using innovative approaches for recruitment which the SMSC has demonstrated in the past and looks forward to building on. The C2P Memphis Coalition and a separate youth community advisory board will over the project period be instrumental in providing input both for clinical trial design as well as youth engagement and retention approaches.
圣犹大儿童研究医院 青少年医学艾滋病毒/艾滋病干预试验网络(ATN)的目标是在7年的资金周期内 开发和实施创新的行为、社区、转化、治疗、杀微生物剂和 针对13-24岁艾滋病毒高危人群和艾滋病毒携带者的疫苗试验,重点是纳入 未成年人。ATN寻找具有创新思维和新颖方法的调查人员向公众发表讲话 青少年面临的健康问题。总部设在孟菲斯的圣裘德·孟菲斯网站联盟(SMSC)位于 在田纳西州的谢尔比县,圣犹大儿童医院有(1)完善的临床和临床研究机构 研究医院(前ATN站点),(2)保护孟菲斯联盟的长期连接(C2P 超过25个利益相关者(基于社区的组织、非营利性组织、孟菲斯学校、 等)投资于青年的利益和(3)建立了伙伴关系,包括与学术界的伙伴关系(哥伦比亚大学 田纳西州)以及当地的谢尔比县和田纳西州卫生部门。谢尔比县是一个 结束艾滋病疫情优先管辖。SMSC与Westat领导的ATN密切合作 运营与协作中心(OCC)将参与临床试验的开发并提供 临床研究地点(S)、当地实验室能力和研究药房支持,以促进ATN 研究议程。对艾滋病毒高危青年和艾滋病毒携带者进行临床试验 他们的诊断将需要使用SMSC已经证明的创新的招聘方法 并期待在过去的基础上再接再厉。C2P孟菲斯联盟和一个单独的青年社区 咨询委员会将在项目期间发挥重要作用,为临床试验设计提供投入 随着青年参与度和留存时间的临近。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Aditya H Gaur其他文献

A call to accelerate antiretroviral development for neonates
呼吁加快新生儿抗逆转录病毒药物的研发
  • DOI:
    10.1016/s2352-3018(23)00307-7
  • 发表时间:
    2024-02-01
  • 期刊:
  • 影响因子:
    13.000
  • 作者:
    Aditya H Gaur;George K Siberry
  • 通讯作者:
    George K Siberry
Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study.
口服和长效注射剂卡博特韦或长效注射剂利匹韦林在病毒学抑制的青少年 HIV 患者中的安全性和药代动力学 (IMPAACT 2017/MOCHA):一项 1/2 期、多中心、开放标签、非比较、剂量探索研究
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Aditya H Gaur;Edmund V. Capparelli;Katherine Calabrese;Kristin Baltrusaitis;M. Marzinke;Cindy McCoig;R. V. Van Solingen;S. R. Mathiba;A. Adeyeye;Jack Moye;Barbara Heckman;Elizabeth D Lowenthal;Shawn Ward;Ryan Milligan;P. Samson;B. Best;Conn M. Harrington;Susan L Ford;Jenny Huang;Herta Crauwels;Kati Vandermeulen;Allison L Agwu;Christiana Smith;Andres Camacho;P. Ounchanum;Jared L Kneebone;Ellen Townley;Carolyn Bolton Moore
  • 通讯作者:
    Carolyn Bolton Moore
Acceptability and tolerability of long-acting injectable cabotegravir or rilpivirine in the first cohort of virologically suppressed adolescents living with HIV (IMPAACT 2017/MOCHA): a secondary analysis of a phase 1/2, multicentre, open-label, non-comparative dose-finding study.
长效注射剂卡博特韦或利匹韦林在第一批病毒学受到抑制的青少年 HIV 感染者中的可接受性和耐受性 (IMPAACT 2017/MOCHA):1/2 期、多中心、开放标签、非比较剂量的二次分析
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Elizabeth D Lowenthal;Jennifer Chapman;Rachel Ohrenschall;Katherine Calabrese;Kristin Baltrusaitis;Barbara Heckman;Dwight E Yin;Allison L Agwu;Conn M. Harrington;R. V. Van Solingen;Cindy McCoig;A. Adeyeye;Jared L Kneebone;Vasiliki Chounta;Christiana Smith;Andres Camacho;Jessica D'Angelo;Allison Bearden;Herta Crauwels;Jenny Huang;Sarah Buisson;Ryan Milligan;Shawn Ward;C. Bolton;Aditya H Gaur
  • 通讯作者:
    Aditya H Gaur
Pharmacokinetics and safety of coformulated bictegravir, emtricitabine, and tenofovir alafenamide in children aged 2 years and older with virologically suppressed HIV: a phase 2/3, open-label, single-arm study
在病毒学抑制的 2 岁及以上儿童中,固定剂量复方比克替拉韦、恩曲他滨和丙酚替诺福韦的药代动力学和安全性:一项 2/3 期、开放标签、单臂研究
  • DOI:
    10.1016/s2352-3018(23)00327-2
  • 发表时间:
    2024-05-01
  • 期刊:
  • 影响因子:
    13.000
  • 作者:
    Carina A Rodriguez;Eva Natukunda;Renate Strehlau;Esme L Venter;Supattra Rungmaitree;Coleen K Cunningham;Umesh Lalloo;Pope Kosalaraksa;Elizabeth HellstrÖm;Afaaf Liberty;Eric J McGrath;Meenu Kaur;Rory Leisegang;Jason T Hindman;Vinicius A Vieira;Kathryn Kersey;Mark F Cotton;Natella Rakhmanina;Aditya H Gaur
  • 通讯作者:
    Aditya H Gaur

Aditya H Gaur的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Aditya H Gaur', 18)}}的其他基金

St. Jude Children's Research Hospital - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
圣裘德儿童研究医院 - 艾滋病毒/艾滋病干预青少年医学试验网络 (ATN) 运营和合作中心(UM2 临床试验可选)
  • 批准号:
    10709610
  • 财政年份:
    2022
  • 资助金额:
    $ 45.66万
  • 项目类别:
St. Jude-Memphis Adolescent Trials Unit
圣裘德-孟菲斯青少年试验中心
  • 批准号:
    8440210
  • 财政年份:
    2006
  • 资助金额:
    $ 45.66万
  • 项目类别:
St. Jude-Memphis Adolescent Trials Unit
圣裘德-孟菲斯青少年试验中心
  • 批准号:
    8248561
  • 财政年份:
    2006
  • 资助金额:
    $ 45.66万
  • 项目类别:
St. Jude-Memphis Adolescent Trials Unit
圣裘德-孟菲斯青少年试验中心
  • 批准号:
    8063772
  • 财政年份:
    2006
  • 资助金额:
    $ 45.66万
  • 项目类别:
St. Jude-Memphis Adolescent Trials Unit
圣裘德-孟菲斯青少年试验中心
  • 批准号:
    8619645
  • 财政年份:
    2006
  • 资助金额:
    $ 45.66万
  • 项目类别:

相似海外基金

Conference: Rethinking how language background is described in academia and beyond
会议:重新思考学术界及其他领域如何描述语言背景
  • 批准号:
    2335912
  • 财政年份:
    2024
  • 资助金额:
    $ 45.66万
  • 项目类别:
    Standard Grant
ADVANCE Catalyst: Virtual Observatory of Culture for Equity in Academia at the University of Puerto Rico Rio Piedras (VoCEA)
ADVANCE Catalyst:波多黎各 Rio Piedras 大学学术界平等文化虚拟观察站 (VoCEA)
  • 批准号:
    2214418
  • 财政年份:
    2023
  • 资助金额:
    $ 45.66万
  • 项目类别:
    Standard Grant
Comprehensive development strategy of modality-specific "intellectual property" and "cultivation" with an eye on "pharmaceutical affairs" in academia drug discovery
学术界新药研发着眼“药事”的模式“知识产权”与“培育”综合发展策略
  • 批准号:
    23K02551
  • 财政年份:
    2023
  • 资助金额:
    $ 45.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accelerating Research Advancement for Investigators Underrepresented in Academia
加速学术界代表性不足的研究人员的研究进展
  • 批准号:
    10746315
  • 财政年份:
    2023
  • 资助金额:
    $ 45.66万
  • 项目类别:
Planning: HBCU-UP: Strengthening Data Science Research Capacity and Education Programs through Academia-Industry Partnership
规划:HBCU-UP:通过学术界与工业界合作加强数据科学研究能力和教育计划
  • 批准号:
    2332161
  • 财政年份:
    2023
  • 资助金额:
    $ 45.66万
  • 项目类别:
    Standard Grant
From Academia to Business: Development of Novel Therapeutics Against HPV-Associated Cancer
从学术界到商界:针对 HPV 相关癌症的新型疗法的开发
  • 批准号:
    10813323
  • 财政年份:
    2023
  • 资助金额:
    $ 45.66万
  • 项目类别:
Academics4Rail: Building a community of railway scientific researchers and academia for ERJU and enabling a network of PhDs (academia teaming with industry)
Academys4Rail:为ERJU建立铁路科研人员和学术界社区并建立博士网络(学术界与工业界合作)
  • 批准号:
    10087488
  • 财政年份:
    2023
  • 资助金额:
    $ 45.66万
  • 项目类别:
    EU-Funded
Academics4Rail: Building a Community of Railway Scientific Researchers and Academia for ERJU and Enabling a Network of PhDs (Academia Teaming with Industry)
Academys4Rail:为二院建立铁路科研人员和学术界社区并启用博士网络(学术界与工业界合作)
  • 批准号:
    10102850
  • 财政年份:
    2023
  • 资助金额:
    $ 45.66万
  • 项目类别:
    EU-Funded
Exploring the overall picture of industry-academia-government collaboration: A spectrum of knowledge transfer through formal and informal channels
探索产学官合作的整体图景:通过正式和非正式渠道进行的一系列知识转移
  • 批准号:
    22K01692
  • 财政年份:
    2022
  • 资助金额:
    $ 45.66万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Fostering Ethical Neurotechnology Academia-Industry Partnerships: A Stakeholder Engagement and Toolkit Development Project
促进道德神经技术学术界与工业界的伙伴关系:利益相关者参与和工具包开发项目
  • 批准号:
    10655632
  • 财政年份:
    2022
  • 资助金额:
    $ 45.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了